HCAT

Health Catalyst, Inc.
CAPPED RATING

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

Health Catalyst, Inc. (HCAT) is rated C- (2.0/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B-); its weakest is Revisions (F). The rating has held at C- for 6 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.0 / 5.0
C-
Value
C-
Factor Score 2.1 / 5.0
Growth
C-
Factor Score 2.0 / 5.0
Profitability
C+
Factor Score 2.7 / 5.0
Momentum
B-
Factor Score 2.9 / 5.0
Revisions
F
Factor Score 0.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 190.7
EV / EBITDA 8.3
Rev Growth YoY -26.3%
Gross Margin 49.5%
Price Return 3M -18.3%
Price Return 12M -49.8%
Catalyst Signal 0.00
Market Cap $108.9M
TTM Revenue $272.2M
Price / Sales 0.4
ROE -84.6%

Historical Factor Score Progression

Held C- for 6 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 C- (2.1) C- (2.0) C+ (2.7) B- (2.9) F (0.0) C- (2.0)
2026-11-05 C- (1.9) C+ (2.6) C+ (2.7) C (2.3) F (0.0) C- (1.9)
2026-10-29 C- (1.9) C+ (2.6) C+ (2.7) C+ (2.8) F (0.0) C- (2.0)
2026-10-22 C- (1.9) C+ (2.6) C+ (2.6) C+ (2.8) F (0.0) C- (2.0)
2026-10-15 C- (1.9) C+ (2.6) C+ (2.6) C+ (2.6) F (0.0) C- (2.0)
Page 1 of 5